Volume 18, Issue 2 (2015)
mjms 2015, 18(2): 53-67 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Atabi F, Mousavi Gargari S L, Hashemi M, Yaghmaei P. Designing and Comparison of Two Types of Chitosan Nanogels for Doxorubicine Delivery. mjms 2015; 18 (2) :53-67
URL: http://mjms.modares.ac.ir/article-30-519-en.html
URL: http://mjms.modares.ac.ir/article-30-519-en.html
1- Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
2- Department of Biology, Faculty of Science, Shahed University, Tehran, Iran
3- Department of Genetics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
2- Department of Biology, Faculty of Science, Shahed University, Tehran, Iran
3- Department of Genetics, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
Abstract: (9317 Views)
Objective: Drug delivery systems related to different cancer therapies is now expanding. Chitosan (CS) is currently receiving enormous interest for medical and pharmaceutical applications due to its biocompatibility in animal tissues. In this study, two nanogels were prepared from CS. Some of the critical factors such as controlling the release, adsorption and specially targeting drug delivery are considered while preparing the nanogels.
Methods: Phosphorylated CS (PCS) and Myristilated CS (MCS) nanogels were prepared by reacting CS with tripolyphosphate (TPP) and Myristate as cross-linking agents respectively and then were loaded with Doxorubicin (DOX). The nanogels were characterized by different techniques such as scanning electron microscopy, dynamic light scattering and Fourier-transform infrared. The cytotoxicity of free DOX, MCS nanogels and DOX loaded MCS was evaluated by the MTT assay.
Results: The result of DOX loading and releasing of the nanogels showed high loading capacity and drug loading efficiency of about 97%. Results indicated slow release of about 16-28% of DOX from PCS within 5 days and 18-40% from MCS within 15 days. DOX and MCS-DOX showed the same toxic effect on the prostate cancer cells (LNCaP).
Conclusion: Both PCS and MCS nanogels were qualified on the basis of size, loading and releasing capacity.
Keywords: Drug delivery, Phosphorylated chitosan nanogels, Myristilated chitosan nanogels, Doxorubicin, Nanomedicine
Article Type: Original Manuscipt |
Subject:
Molecular Biology
Received: 2015/03/7 | Accepted: 2015/06/22
Received: 2015/03/7 | Accepted: 2015/06/22
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |